Specialty Pharmacy

Metformin decreased inflammation and scarring observed in more common pancreatic cancers.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses what comprises an effective pharmacy accreditation program.

Combination of diclofenac with chemotherapy and radiation may greatly improve treatment of cancer patients.

Pomalyst was approved in 2013 for use in combination with dexamethasone to inhibit tumor growth.

Health care coverage among parents has increased, but many remain unable to afford coverage.

Cheese contains a natural food preservative, nisin, which can destroy cancer cells.

BioMarin Pharmaceutical Inc's new drug application for drisapersen as a treatment for Duchenne muscular dystrophy has been rejected by the FDA.

Unexplained drug cost increases are the epicenter of some of the most polemic conversations in US health policy today.

Cosentyx was previously approved for the treatment of moderate-to-severe plaque psoriasis.

Few state minor-consent laws authorize participation in clinical trials and therapies.

Pricing Sovaldi based on the predicted benefits of therapy in specific hepatitis C patient groups could ultimately lead to greater access for patients.

Large geographic disparities exist in the likelihood of either being removed from the transplant list due to progressive disease or actually receiving a transplant.

Process attaches disease-related protein fragments to spleen cells to prevent MS.

Predictors of higher cost include older age, male sex, and hospital location.

Patients with type 2 diabetes have about a 60% greater risk for developing dementia than their non-diabetic counterparts.

Whether transient, spontaneous, or a triggered exacerbation of adequately controlled baseline aches, breakthrough pain is a difficult symptom for providers to gauge.

Research examines long non-coding RNAs as biomarkers and therapeutic targets.

Top news of the week in cancer drug development and research.

PKN proteins are gaining recognition as drug targets for cancer research.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

Tumor depth associated with the highest risk risk ratio of local recurrence.

Government announces plans to increase funding for cancer treatment research and development.

Multi-ingredient capsule funnels different ingredients through 2 parallel inner needles, which could enhance cancer treatment.

Top stories of the week on Specialty Pharmacy Times.

Pair of daily ribavirin-free oral drugs will be analyzed in patients with hepatitis C genotypes 1-6.

A proposal to reduce Medicare Part B payment rates for hospitals participating in the 340B Drug Pricing Program has been approved 14-3 by the Medicare Payment Advisory Commission.

Consistent PrEP use can lower the risk of HIV infection by 92% among those at high risk for transmission.

Many patients with diabetes have high levels of mental illness, multiple comorbidities, and unmet needs.